Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.1 EX-3.1
- 3.1.1 EX-3.1.1
- 3.3 EX-3.3
- 4.1 EX-4.1
- 4.2 EX-4.2
- 4.4 EX-4.4
- 10.2 EX-10.2
- 10.6 EX-10.6
- 10.7 EX-10.7
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.12 EX-10.12
- 10.13 EX-10.13
- 10.14 EX-10.14
- 10.15 EX-10.15
- 10.16 EX-10.16
- 10.17 EX-10.17
- 10.18 EX-10.18
- 10.19 EX-10.19
- 16.1 EX-16.1
- 21.1 EX-21.1
- 23.2 EX-23.2
Associated filings
GDRX similar filings
Filing view
External links
Exhibit 16.1
Crowe LLP | ||||
Independent Member Crowe Global |
August 28, 2020
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, N. E.
Washington, D.C. 20549
Ladies and Gentlemen:
We have read the section entitled “Changes in Accountants” in the Registration Statement on Form S-1 of GoodRx Holdings, Inc. (the “Company”) and agree with paragraphs 1, 2, 3 and 4.
With respect to paragraph 6, we are not in a position to agree or disagree with the Company’s statement regarding the engagement of PricewaterhouseCoopers LLP. We have no basis to agree or disagree with other statements of the Company contained therein.
/s/ Crowe LLP
Crowe LLP